NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides — playbook

NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides

NeuroBo Pharmaceuticals · 2023-12

arc beats above · slides in the middle · loops below · scroll → 2 LOOPS

Deck intelligence map

5

coverage by narrative range · generated from this deck JSON

Narrative range 18 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits

— 0/2 slides

50% 1/2 slides · 2 hits 50% 1/2 slides 100% 2/2 slides

— 0/2 slides

Solution 5 slides 100% 5/5 slides 100% 5/5 slides · 22 hits

— 0/5 slides

60% 3/5 slides 20% 1/5 slides 100% 5/5 slides 80% 4/5 slides Product 8 slides 100% 8/8 slides 100% 8/8 slides · 37 hits

— 0/8 slides

50% 4/8 slides 50% 4/8 slides 100% 8/8 slides

— 0/8 slides

Team 1 slides 100% 1/1 slides 100% 1/1 slides · 15 hits

— 0/1 slides

100% 1/1 slides · 2 hits

— 0/1 slides

100% 1/1 slides

— 0/1 slides

Financials 2 slides 100% 2/2 slides 100% 2/2 slides · 6 hits

— 0/2 slides

50% 1/2 slides

— 0/2 slides

100% 2/2 slides

— 0/2 slides

Slide inventory

25

every slide · same image gating as the playbook

01

Includes company logo, name, ticker symbol, and date.front_matter

Open slide detail

02

other

Open slide detail

03

other

Open slide detailBeat · Team

04

summarize

Open slide detailBeat · Problem

05

The slide uses a standard pharmaceutical pipeline table format.plan_implementation

Open slide detailBeat · Problem

06

plan_implementation

Open slide detail

07

front_matter

Open slide detailBeat · Solution

08

The table highlights clinical status, mechanism of action, efficacy, safety, and strategic differentiation.compare_peers

Open slide detailBeat · SolutionLoop · Pattern Hunter

09

The slide uses a biological process flow to explain the mechanism of action.present_solution

Open slide detailBeat · SolutionLoop · Pattern Hunter

10

Includes two heatmaps showing gene expression changes and a biological pathway diagram for GLP1 receptor activation.present_solution

Open slide detailBeat · SolutionLoop · Pattern Hunter

11

Includes study references and definitions for GPR119, MASH, GLP-1, and drug dosages.analyze_data

Open slide detailBeat · SolutionLoop · Pattern Hunter

12

The slide presents 11 distinct bar charts summarizing a study on drug efficacy in a mouse model of MASH (Metabolic dysfunction-associated steatohepatitis).analyze_data

Open slide detail

13

Notes at bottom define FPFV and LPO.show_traction

Open slide detailBeat · Product

14

The slide uses a hub-and-spoke diagram to illustrate the multi-faceted mechanism of action of the drug target.present_solution

Open slide detailBeat · Product

15

front_matter

Open slide detailBeat · Product

16

The table highlights DA-1726's dual agonist mechanism and potential for better tolerability compared to market leaders.compare_peers

Open slide detailBeat · Product

17

The slide uses a hub-and-spoke diagram to illustrate the systemic effects of oxyntomodulin.present_solution

Open slide detailBeat · Product

18

The slide uses three charts: a bar chart for food intake and two line charts for body weight loss (BWL) in different mouse models.compare_peers

Open slide detailBeat · Product

19

The slide highlights that DA-1726 achieves weight loss through mechanisms other than just food reduction, as evidenced by higher food intake compared to Tirzepacompare_peers

Open slide detailBeat · Product

20

Includes study design, population, and location details.analyze_data

Open slide detailBeat · Product

21

transition

Open slide detailBeat · Financials

22

WAEP stands for Weighted Average Exercise Price.analyze_data

Open slide detailBeat · Financials

23

establish_context

Open slide detailLoop · Why Now

24

summarize

Open slide detailLoop · Why Now

25

state_next_steps

Open slide detail